CORRECTION OF ANAEMIA WITH ERYTHROPOIETIN IN CKD/ESRD PATIENTS
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2015, Vol 4, Issue 12
Abstract
Chronic kidney disease (CKD) is characterized by gradual and permanent loss of kidney function. One of the most common complications of CKD is Anaemia.1,3 Anaemia often appears earlier in course of CKD and worsens with disease progression.1,2 Erythropoietin is a hormone synthesized in the kidney is deficient in the majority of patients of CKD thereby predisposing them for developing anaemia. Erythropoiesis stimulating agents ESAs) first became clinically available in 1989 and has contributed to the advances in the management of CKD related anemia. The present study highlights the correction of anaemia with erythropoietin (Eprex) in population having CKD on MHD and anaemia. Based on GFR CKD is divided into five stages from 1-5. Patients often become anaemic at stage 3 or 4 CKD but anaemia may develop as early as stage 2. And it is present in the majority of patients with stage 5 disease.2,4 The objective of this study is to evaluate efficacy of administration of 10000.U. Epotin alfa sc for once a week as initiation therapy in patients with anaemia of CKD/ESRD on MHD for 28 weeks of duration of treatment. It is a prospective study done at Central Hospital, South Central Railway, Secunderabad on patients with ESRD or stage 4 on maintenance hemodialysis and receiving subcutaneously EPO (Eprex). Serum feritin and %transferrin saturation are estimated before the initiation of EPO(Eprex) & if the levels are below normal, IV IRON 100 mg is given once weekly and oral elemental Iron 200 to 400 mg to every to normalize the serum ferritin and % transferrin saturation levels. Hemoglobin level estimation has done before and after the initiation of the EPO (Eprex) and once in weekly and four weekly to see the response more than 1gm in four weeks to achieve the target hemoglobin level (11 to 12 grams) in 28 weeks. In the present study target hemoglobin level (11-12g/dl) was achieved in 42 out of 50 patients under consideration (84%) in 28 weeks of duration of treatment and not achieved for 8 amongst 50(16%) patients. Increase in the hemoglobin level of 1/dl is seen in 13(26%),>1 g/dl in 29(58%) and <1 g/dl in 8(16%) patients.
Authors and Affiliations
Madhukar Gaikwad, Shyamal Sinha, Rashmi Sinha, Anitha Gore, Bhattacharjee S, Anjaiah T, Abdul Hannan, Kunal Patankar
Keywords
Related Articles
- EP ID EP106419
- DOI 10.14260/jemds/2015/280
- Views 115
- Downloads 0
EFFECT OF SHORT-TERM YOGA PRACTICES ON PSYCHOLOGICAL GENERAL WELL BEING IN MEDICAL STUDENTS
Yoga is assuming importance in improving mental health and quality of life and in the treatment of a number of psychiatric and psychosomatic disorders. Medical students are foundation of the medical profession;...
A STUDY OF CLINICAL AND HAEMATOPATHOLOGICAL CORRELATION OF HAEMOLYTIC ANAEMIAS IN CHILDREN
Anaemia is a manifestation of disease, not a disease in itself. Anaemia is a frequent laboratory abnormality in children. As many as 80 children in developing countries will be anaemic at some point by the age of...
IMPACT OF DIABETES MELLITUS ON TREATMENT OUTCOME OF MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS
BACKGROUND Multiple studies have indicated that patients of pulmonary tuberculosis with diabetes mellitus may experience poor outcome. Emergence of Multidrug Resistant-TB has further complicated the situation, as its man...
PATTERN OF SUBSTANCE USE IN A DRUG DEADDICTION CENTRE IN DIPHU- NORTHEAST INDIABASED STUDY
BACKGROUND India is a multicultural and multilingual democracy; the use of different substances is found to be regionally diversified. Ethnic variations have contributed to this diversification and so a single study on a...
CLINICOETIOLOGICAL PROFILE OF FIRST EPISODE SEIZURE IN CHILDREN 1 MONTH TO 12 YEARS
BACKGROUND Seizures are one of the most common neurological causes of childhood hospitalization having significant mortality and morbidity. There was limited data regarding acute seizure episodes in paediatric population...